Data Insights
No filters selected
No filters selected
No filters selected
No filters selected
GSBR-1290 by Structure Therapeutics for Type 2 Diabetes: Likelihood of Approval
GSBR-1290 is under clinical development by Structure Therapeutics and currently in Phase II for Type 2 Diabetes. According to GlobalData,...
GSBR-1290 by Structure Therapeutics for Obesity: Likelihood of Approval
GSBR-1290 is under clinical development by Structure Therapeutics and currently in Phase II for Obesity. According to GlobalData, Phase II...
LTSE-2578 by Structure Therapeutics for Idiopathic Pulmonary Fibrosis: Likelihood of Approval
LTSE-2578 is under clinical development by Structure Therapeutics and currently in Phase I for Idiopathic Pulmonary Fibrosis. According to GlobalData,...